Tag: pharma R&D

Global Regulatory Expectations Shaping Target Identification & Preclinical Pathways in the US, EU and UK Global Regulatory Expectations Shaping Target Identification & Preclinical Pathways in the US, EU and UK In the fast-paced landscape of pharmaceutical research and development, understanding global regulatory expectations is paramount for successful target identification and preclinical pathways. This tutorial aims…

Read More “Global Regulatory Expectations Shaping Target Identification & Preclinical Pathways in the US, EU and UK” »

Partnering, Outsourcing and Alliances to Scale Target Identification & Preclinical Pathways Partnering, Outsourcing and Alliances to Scale Target Identification & Preclinical Pathways Introduction to Target Identification in Drug Development Target identification is a fundamental yet complex phase in the drug development process, serving as the groundwork for subsequent stages such as drug design, testing, and…

Read More “Partnering, Outsourcing and Alliances to Scale Target Identification & Preclinical Pathways” »

Common Pitfalls in Target Identification & Preclinical Pathways—and How to Avoid Costly Rework Common Pitfalls in Target Identification & Preclinical Pathways—and How to Avoid Costly Rework In the landscape of pharmaceutical research and development, particularly in the context of target identification and preclinical pathways, navigating the intricate pathways is crucial. Understanding the common pitfalls can…

Read More “Common Pitfalls in Target Identification & Preclinical Pathways—and How to Avoid Costly Rework” »

Target Identification & Preclinical Pathways: Strategic Playbook for Modern Pharma R&D Target Identification & Preclinical Pathways: Strategic Playbook for Modern Pharma R&D The development of new pharmaceuticals is a complex process that begins with target identification and progresses through various preclinical pathways before reaching clinical trials. In this article, we provide a detailed guide tailored…

Read More “Target Identification & Preclinical Pathways: Strategic Playbook for Modern Pharma R&D” »

How to Design Target Identification & Preclinical Pathways That Accelerates Time-to-Proof-of-Concept How to Design Target Identification & Preclinical Pathways That Accelerates Time-to-Proof-of-Concept In the highly competitive landscape of pharmaceutical R&D, the challenge of shortening the pathway from target identification to proof-of-concept (PoC) is crucial. This article provides a comprehensive, step-by-step tutorial on how to effectively…

Read More “How to Design Target Identification & Preclinical Pathways That Accelerates Time-to-Proof-of-Concept” »

Target Identification & Preclinical Pathways in Practice: Case Studies, Workflows and Governance Models Target Identification & Preclinical Pathways in Practice: Case Studies, Workflows and Governance Models The pharmaceutical landscape is evolving rapidly, driven by advancements in science, technology, and regulatory expectations. With the increase in competition and complexity in clinical development, a robust understanding of…

Read More “Target Identification & Preclinical Pathways in Practice: Case Studies, Workflows and Governance Models” »

High-Impact Target Identification & Preclinical Pathways Tactics That De-Risk Clinical Development Introduction to Target Identification in Clinical Development In the pharmaceutical industry, effective target identification is a crucial step that lays the foundation for successful drug development. Identifying the correct biological pathway is essential for the design and execution of clinical trials, guiding the selection…

Read More “High-Impact Target Identification & Preclinical Pathways Tactics That De-Risk Clinical Development” »

Integrating Target Identification & Preclinical Pathways With Clinical Development, CMC and Market Access The successful development of new therapeutic agents depends on a seamless integration of target identification, preclinical pathways, and clinical development. In this guide, we explore the foundational strategies that underpin pharmaceutical R&D, focusing on the importance of coherent workflows that propel drug…

Read More “Integrating Target Identification & Preclinical Pathways With Clinical Development, CMC and Market Access” »